These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22539846)

  • 41. Effects of the serotonin 2C receptor agonist WAY163909 on the abuse-related effects and mesolimbic dopamine neurochemistry induced by abused stimulants in rhesus monkeys.
    Berro LF; Perez Diaz M; Maltbie E; Howell LL
    Psychopharmacology (Berl); 2017 Sep; 234(17):2607-2617. PubMed ID: 28584928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.
    Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M
    Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users.
    Moeller SJ; Okita K; Robertson CL; Ballard ME; Konova AB; Goldstein RZ; Mandelkern MA; London ED
    Neuropsychopharmacology; 2018 Mar; 43(4):751-760. PubMed ID: 28664927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
    Nishikawa T; Mataga N; Takashima M; Toru M
    Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.
    Kohno M; Okita K; Morales AM; Robertson CL; Dean AC; Ghahremani DG; Sabb FW; Rawson RA; Mandelkern MA; Bilder RM; London ED
    Mol Psychiatry; 2016 Nov; 21(11):1554-1560. PubMed ID: 26830141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning.
    Groman SM; Lee B; London ED; Mandelkern MA; James AS; Feiler K; Rivera R; Dahlbom M; Sossi V; Vandervoort E; Jentsch JD
    J Neurosci; 2011 May; 31(20):7291-9. PubMed ID: 21593313
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prenatal and neonatal exposure to bisphenol-A enhances the central dopamine D1 receptor-mediated action in mice: enhancement of the methamphetamine-induced abuse state.
    Suzuki T; Mizuo K; Nakazawa H; Funae Y; Fushiki S; Fukushima S; Shirai T; Narita M
    Neuroscience; 2003; 117(3):639-44. PubMed ID: 12617968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.
    Huang J; Yang G; Li Z; Leung CK; Wang W; Li Y; Liu L; Shen B; He C; He Y; Zeng X; Li J
    Brain Behav; 2020 Feb; 10(2):e01533. PubMed ID: 31943832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.
    Kreisler AD; Terranova MJ; Somkuwar SS; Purohit DC; Wang S; Head BP; Mandyam CD
    Brain Struct Funct; 2020 Apr; 225(3):1073-1088. PubMed ID: 32246242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission.
    Sambo DO; Lin M; Owens A; Lebowitz JJ; Richardson B; Jagnarine DA; Shetty M; Rodriquez M; Alonge T; Ali M; Katz J; Yan L; Febo M; Henry LK; Bruijnzeel AW; Daws L; Khoshbouei H
    Nat Commun; 2017 Dec; 8(1):2228. PubMed ID: 29263318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cholinergic neuronal modulation alters dopamine D2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: positron emission tomography studies with microdialysis in the conscious monkey brain.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Kakiuchi T
    J Neurosci; 2000 Sep; 20(18):7067-73. PubMed ID: 10995853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction.
    Itzhak Y; Ali SF
    Ann N Y Acad Sci; 2002 Jun; 965():127-35. PubMed ID: 12105090
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
    Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential associations of dopamine synthesis capacity with the dopamine transporter and D2 receptor availability as assessed by PET in the living human brain.
    Yamamoto Y; Takahata K; Kubota M; Takano H; Takeuchi H; Kimura Y; Sano Y; Kurose S; Ito H; Mimura M; Higuchi M
    Neuroimage; 2021 Feb; 226():117543. PubMed ID: 33186713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amphetamine sensitization impairs cognition and reduces dopamine turnover in primate prefrontal cortex.
    Castner SA; Vosler PS; Goldman-Rakic PS
    Biol Psychiatry; 2005 Apr; 57(7):743-51. PubMed ID: 15820231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.